维普中文期刊产品整合服务
270篇 您的检索式:作者名="IZBICKI"
    题名 作者 年代 出处 被引量
1Postoperative pancreatic fistula: An international study group (ISGPF) definition显示文摘Claudio Bassi Christos Dervenis Giovanni Butturini Abe Fingerhut Charles Yeo Jakob Izbicki John Neoptolemos Michael Sarr William Traverso Marcus Buchler 2005Surgery2005,,1:9
2Postoperative pancreatic fistula: An international study group (ISGPF) definition显示文摘Claudio Bassi Christos Dervenis Giovanni Butturini Abe Fingerhut Charles Yeo Jakob Izbicki John Neoptolemos Michael Sarr William Traverso Marcus Buchler 2005Surgery2005,,1:6
3Oxygen radical formation does not have an impact in the treatment of severe acute experimental pancreatitis using free cellular hemoglobin显示文摘瞄准:Microcirculatory 机能障碍和免费的氧激进分子是在严重尖锐胰腺炎的致病的重要因素。另外的氧交货可能每氧化提高类脂化合物,但是可以也改进胰腺的微循环。这研究在严重尖锐胰腺炎的一个啮齿类动物模型在氧激进分子和微循环的形成上估计免费细胞的牛的血红素的效果。方法:在尖锐胰腺炎 Wistar 老鼠的正式就职以后的十五分钟收到了任何一个 0.8 mL 牛的血红素(HBOC-200 ) , hydroxyethyl 淀粉(HES ) 或保证血量正常替换的生理盐水的 2.4 mL。在检查的 6 h 以后,胰每氧化产品 malondialdehyde (MDA ) 为类脂化合物的间接测量被切除并且很快处理了并且在胰腺的织物减少了谷胱甘肽(GSH ) 。结果:HBOC-200 的单个申请改进了胰腺的微循环并且显著地减少了组织病理学说的织物损坏。MDA 的织物集中没在这些组之间不同。另外,在 GSH 层次的差别都没被检测。结论:不过 HBOC-200 和 HES 的单个申请改进胰腺的微循环,在类脂化合物的没有差别每氧化,产品被检测。另外的氧供应(HBOC-200 ) 的有益的效果不每氧化导致提高的类脂化合物。Helge Kleinhans Oliver Mann Paulus G Schurr Jussuf T Kaifi Bente Hansen Jakob R Izbicki Tim Strate 2006World Journal of Gastroenterology2006,12,18:6
4Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)显示文摘Moritz N. Wente Claudio Bassi Christos Dervenis Abe Fingerhut Dirk J. Gouma Jakob R. Izbicki John P. Neoptolemos Robert T. Padbury Michael G. Sarr L. William Traverso Charles J. Yeo Markus W. Büchler 2007Surgery2007,,5:4
5Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy显示文摘AIM: To study the prognostic value of adjuvant chemo-therapy in patients with pancreatic, ductal adenocar-cinoma.METHODS: Lymph nodes from 106 patients with resectable pancreatic ductal adenocarcinoma were systematically sampled. A total of 318 lymph nodes classified histopathologically as tumor-free were examined using sensitive immunohistochemical assays. Forty-three (41%) of the 106 patients were staged as pT1/2, 63 (59%) as pT3/4, 51 (48%) as pN0, and 55 (52%) as pN1. The study population included 59 (56%) patients exhibiting G1/2, and 47 (44%) patients with G3 tumors. Patients received no adjuvant chemo- or radiation therapy and were followed up for a median of 12 (range: 3.5 to 139) mo.RESULTS: Immunostaining with Ber-EP4 revealed nodal microinvolvement in lymph nodes classified as “tumor free” by conventional histopathology in 73 (69%) out of the 106 patients. Twenty-nine (57%)of 51 patients staged histopathologically as pN0 had nodal microinvolvement. The five-year survival probability for pN0-patients was 54% for those without nodal microinvolvement and 0% for those with nodal microinvolvement. Cox-regression modeling revealed the independent prognostic effect of nodal microinvolvement on recurrence-free (relative risk 2.92, P = 0.005) and overall (relative risk 2.49, P = 0.009) survival.CONCLUSION: The study reveals strong and independent prognostic significance of nodal microinvolvement in patients with pancreatic ductal adenocarcinoma who have received no adjuvant therapy. The addition of immunohistochemical findings to histopathology reports may help to improve risk stratification of patients with pancreatic cancer.Emre F Yekebas Dean Bogoevski Michael Bubenheim Bjrn-Christian Link Jussuf T Kaifi Robin Wachowiak Oliver Mann Asad Kutup Guellue Cataldegirmen Lars Wolfram Andreas Erbersdobler Christoph Klein Klaus Pantel Jakob R Izbicki 2006World Journal of Gastroenterology2006,12,40:3
6HER-2 amplification is highly homogenous in gastric cancer显示文摘Andreas H. Marx Lars Tharun Johanna Muth Ana-Maria Dancau Ronald Simon Emre Yekebas Jussuf T. Kaifi Martina Mirlacher Tim H. Brümmendorf Carsten Bokemeyer Jakob R. Izbicki Guido Sauter 2009Human Pathology2009,,6:3
7The impact of early goal-directed fluid management on survival in an experimental model of severe acute pancreatitis显示文摘Constantin J. C. Trepte Kai A. Bachmann Jan H. Stork Till J. Friedheim Andrea Hinsch Matthias S. Goepfert Olliver Mann Jakob R. Izbicki Alwin E. Goetz Daniel A. Reuter 2013Intensive Care Medicine2013,,4:2
8Postpancreatectomy hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) definition显示文摘Moritz N. Wente Johannes A. Veit Claudio Bassi Christos Dervenis Abe Fingerhut Dirk J. Gouma Jakob R. Izbicki John P. Neoptolemos Robert T. Padbury Michael G. Sarr Charles J. Yeo Markus W. Büchler 2007Surgery2007,,1:2
9Essentials in surgery for chronic pancreatitis显示文摘Izbicki JR Bloechle C 2001Dig Surg2001,18,2:1
10Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis显示文摘Segel M J Izbicki G Cohen P Y 2003Am J Physiol Lung Cell Mol Physiol2003,285,11:1
11Role of soluble interleukin-2 receptor levels in patients with latent tuberculosis显示文摘Shitrit D Izbicki G Bar-Gil Shitrit A 2006Lung2006,184,1:1
12Mode of spread in the early phase of lymphatic metastasis 显示文摘Izbicki J Passlick B Hosch SB 1996J Thorac Car- diovasc Surg1996,112,3:1
13Postoperative pancreatic fistula: An international study group (ISGPF) definition显示文摘Claudio Bassi Christos Dervenis Giovanni Butturini Abe Fingerhut Charles Yeo Jakob Izbicki John Neoptolemos Michael Sarr William Traverso Marcus Buchler 2005Surgery2005,,1:1
14Extended drainage versus resection in surgery for chronic pancreatitis:a prospective randomized trial comparing the longitudinal pancreaticojejunostomy combined with local pancreatic head excision with the pylorus-preserving pancreatoduodenectomy显示文摘Izbicki JR Bloechle C Broering DC 1998Ann Surg1998,228,6:1
15Prognostic value of a new quantitative D-dimer test in critically ill patients 24 and 48 h following admission to the intensive care unit显示文摘Shitrit D Izbicki G Shitrit AB 2004Blood Coagul Fibrinolysis2004,15,1:1
16Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer 显示文摘Izbicki JR Hosch SB Pichlmeier U 1997N Engl J ned1997,337,17:1
17Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer显示文摘Passlick B Kubuschok B Izbicki JR 1999Ann Thorac Surg1999,68,6:1
18Extra-hepatic portal hypertension in chronic pancreatitis:an old problem revisited显示文摘Izbicki JR Yekebas EF Strate T 2002Ann Surg2002,236,1:1
19Immunohistochemical assessment of patients with non small cell lung cancer显示文摘Passlick B Izbicki J R Kubuschok B 1994J Clin Oncol1994,12,9:1
20Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway 显示文摘Wallach-Dayan SB Izbicki G Cohen PY 2005Am J Physiol Lung Cell Mol Physiol2005,23,11:1
返回顶部 每页显示:
共14页 首页 上一页 第1页 下一页 末页 /14 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费